Eliem Therapeutics Inc (ELYM)
8.98
-1.18
(-11.57%)
USD |
NASDAQ |
May 06, 14:19
Eliem Therapeutics EPS Diluted (Quarterly): -0.13 for Dec. 31, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.13 |
| September 30, 2023 | -0.15 |
| June 30, 2023 | -0.19 |
| March 31, 2023 | -0.84 |
| December 31, 2022 | -0.29 |
| September 30, 2022 | -0.37 |
| June 30, 2022 | -0.56 |
| March 31, 2022 | -0.50 |
| Date | Value |
|---|---|
| December 31, 2021 | -0.40 |
| September 30, 2021 | -0.70 |
| June 30, 2021 | -0.463 |
| March 31, 2021 | -1.688 |
| December 31, 2020 | -1.354 |
| September 30, 2020 | -0.2332 |
| June 30, 2020 | -0.1786 |
| March 31, 2020 | -0.2019 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-1.688
Minimum
Mar 2021
-0.13
Maximum
Dec 2023
-0.5156
Average
-0.385
Median
EPS Diluted (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | 0.15 |
| Candel Therapeutics Inc | -0.38 |
| Cyclacel Pharmaceuticals Inc | -6.23 |
| Lipocine Inc | -0.42 |
| GlycoMimetics Inc | -0.14 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.641M |
| Total Expenses (Quarterly) | 5.122M |
| Enterprise Value | 174.69M |
| Earnings Yield | -14.59% |